Home      About this journal      Authors      Editors      Readers      Archive      Contact us
Effect of Jingui Shenqi Pill on inhibition of apoptosis and autophagy of lung tissue through AMPK/mTOR pathway in rats with chronic obstructive pulmonary disease
Hits 868  Download times 591  Received:April 12, 2020  
View Full Text  View/Add Comment  Download reader
DOI   10.11656/j.issn.1672-1519.2021.06.23
Key Words   Jingui Shenqi Pill;chronic obstructive pulmonary disease;apoptosis;autophagy;AMPK/mTOR pathway
Author NameAffiliationE-mail
LIU Ming Department of Integrated Traditional Chinese and Western Medicine, Zhuzhou Central Hospital, Zhuzhou 412000, China  
XIE Li Department of Integrated Traditional Chinese and Western Medicine, Zhuzhou Central Hospital, Zhuzhou 412000, China  
PI Miao Department of Integrated Traditional Chinese and Western Medicine, Zhuzhou Central Hospital, Zhuzhou 412000, China  
WANG Ling Department of Integrated Traditional Chinese and Western Medicine, Zhuzhou Central Hospital, Zhuzhou 412000, China 1065984389@qq.com 
Abstract
    [Objective] To explore the effect of Jingui Shenqi Pills on chronic obstructive pulmonary disease (COPD) and its possible mechanism.[Methods] Forty SD rats were randomly divided into control group,COPD group,Jingui Shenqi Pills 3.7 g/kg group,Jingui Shenqi Pills 7.4 g/kg group and dexamethasone group,8 rats in each group. Except for the control group,the rats in the remaining groups were established with COPD rats by smoking combined with intratracheal lipopolysaccharide (LPS) method. Each group was given corresponding drug treatment. AniRes2005 animal lung function analysis system was used to detect rat lung function. ELISA kits were used to detect the levels of IL-1β,TNF-α,IL-6 and IL-17. HE staining was used to detect lung histopathological changes. TUNEL staining was used to detect the cell apoptosis of lung tissue. Western blot was used to detect the autophagy and AMPK/mTOR pathway related protein expression.[Results] Compared with the control group,the lung function of rats in COPD group was reduced,and the levels of IL-1β,TNF-α,IL-6 and IL-17 were significantly increased (P<0.05),inflammation score,apoptosis rate and LC3Ⅱ/LC3Ⅰ,Beclin1,p-AMPK/AMPK protein expression levels were significantly increased (P<0.05),p62 and p-mTOR/mTOR protein expression levels were significantly reduced (P<0.05);compared with COPD group,pulmonary function was increased in the Jingui Shenqi Pills 3.7 g/kg group,Jingui Shenqi Pill 7.4g/kg group and the dexamethasone group,and the levels of IL-1β,TNF-α,IL-6 and IL-17 were significantly reduced (P<0.05),inflammation score,apoptosis rate and LC3Ⅱ/LC3Ⅰ,Beclin1,p-AMPK/AMPK protein expression levels were significantly reduced (P<0.05),p62 and p-mTOR/mTOR protein expression levels were significantly increased (P<0.05).[Conclusion] Jingui Shenqi Pills may inhibit the apoptosis and autophagy of lung tissue through the AMPK/mTOR pathway,and delay the progression of chronic obstructive pulmonary disease in rats.

You are the 2318552 visitor.

Copyright @ 2007
Address: 10 Boyanghu Road, West District of Tuanbo New City, Jinghai District, Tianjin 301617, China  Postcode:
Tel:  Fax:  E-mail:
Beijing E-Tiller Co., Ltd.